On Fβ -score for medical diagnostics tests of binary diseases: proposing new measures of accuracy.

IF 1.2 4区 医学 Q4 PHARMACOLOGY & PHARMACY
Marwan Alsharman, Hani Samawi, Jing Kersey, Divine Wanduku
{"title":"On F<sub>β</sub> -score for medical diagnostics tests of binary diseases: proposing new measures of accuracy.","authors":"Marwan Alsharman, Hani Samawi, Jing Kersey, Divine Wanduku","doi":"10.1080/10543406.2025.2469866","DOIUrl":null,"url":null,"abstract":"<p><p>Accurate differentiation between health states - diseased or non-diseased - is essential in clinical diagnostics. Optimal cut-off points, or thresholds used to classify test results, are crucial for precise diagnoses. This work introduces the Harmonic Mean of F-score and inverse F-score (<i>HF</i>), a novel metric for a balanced assessment of diagnostic accuracy. <i>HF</i> integrates Specificity (<i>Sp</i>) and Negative Predictive Value (NPV) into the Negative F-score (<i>NF</i><sub><i>γ</i></sub>), ensuring a comprehensive evaluation of true negatives and negative test reliability. Prioritizing both true positives and true negatives, <i>HF</i> was used in optimal cut-off point estimation under binary disease classification. Simulation results revealed that the <i>HF</i> measure performed well, often surpassing established methods in specific settings. The <i>HF</i> measure and cut-off point selection criterion were applied to real-life data, showcasing its ability to provide a balanced evaluation of diagnostic accuracy. The <i>HF</i> measure frequently outperformed traditional metrics. The <i>HF</i> metric's flexibility, allowing parameter adjustments to accommodate diverse scenarios, enables researchers and clinicians to tailor its emphasis on specific aspects of diagnostic performance depending on the context.</p>","PeriodicalId":54870,"journal":{"name":"Journal of Biopharmaceutical Statistics","volume":" ","pages":"1-27"},"PeriodicalIF":1.2000,"publicationDate":"2025-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Biopharmaceutical Statistics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/10543406.2025.2469866","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Accurate differentiation between health states - diseased or non-diseased - is essential in clinical diagnostics. Optimal cut-off points, or thresholds used to classify test results, are crucial for precise diagnoses. This work introduces the Harmonic Mean of F-score and inverse F-score (HF), a novel metric for a balanced assessment of diagnostic accuracy. HF integrates Specificity (Sp) and Negative Predictive Value (NPV) into the Negative F-score (NFγ), ensuring a comprehensive evaluation of true negatives and negative test reliability. Prioritizing both true positives and true negatives, HF was used in optimal cut-off point estimation under binary disease classification. Simulation results revealed that the HF measure performed well, often surpassing established methods in specific settings. The HF measure and cut-off point selection criterion were applied to real-life data, showcasing its ability to provide a balanced evaluation of diagnostic accuracy. The HF measure frequently outperformed traditional metrics. The HF metric's flexibility, allowing parameter adjustments to accommodate diverse scenarios, enables researchers and clinicians to tailor its emphasis on specific aspects of diagnostic performance depending on the context.

二元疾病医学诊断试验的Fβ评分:提出新的准确性测量方法。
在临床诊断中,准确区分患病或非患病的健康状态至关重要。用于对测试结果进行分类的最佳截止点或阈值对于精确诊断至关重要。这项工作介绍了f -分数和反f -分数(HF)的谐波平均值,这是一种平衡评估诊断准确性的新指标。HF将特异性(Sp)和阴性预测值(NPV)整合到阴性f评分(NFγ)中,确保了对真阴性和阴性测试信度的全面评估。对真阳性和真阴性进行优先排序,将HF用于二元疾病分类下的最佳截断点估计。仿真结果表明,高频测量表现良好,在特定设置中往往优于既定方法。HF测量和截断点选择标准应用于实际数据,展示了其提供诊断准确性平衡评估的能力。高频度量通常优于传统度量。HF指标的灵活性,允许参数调整以适应不同的情况,使研究人员和临床医生能够根据具体情况量身定制诊断性能的特定方面。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Biopharmaceutical Statistics
Journal of Biopharmaceutical Statistics 医学-统计学与概率论
CiteScore
2.50
自引率
18.20%
发文量
71
审稿时长
6-12 weeks
期刊介绍: The Journal of Biopharmaceutical Statistics, a rapid publication journal, discusses quality applications of statistics in biopharmaceutical research and development. Now publishing six times per year, it includes expositions of statistical methodology with immediate applicability to biopharmaceutical research in the form of full-length and short manuscripts, review articles, selected/invited conference papers, short articles, and letters to the editor. Addressing timely and provocative topics important to the biostatistical profession, the journal covers: Drug, device, and biological research and development; Drug screening and drug design; Assessment of pharmacological activity; Pharmaceutical formulation and scale-up; Preclinical safety assessment; Bioavailability, bioequivalence, and pharmacokinetics; Phase, I, II, and III clinical development including complex innovative designs; Premarket approval assessment of clinical safety; Postmarketing surveillance; Big data and artificial intelligence and applications.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信